About US
Contact us
-
Novartis plant's quality control understaffed, inadequately trained, FDA saysNovartis ($NVS) temporarily pulled the curtains on its Lincoln, NE, consumer drug plant in late December. What's been going on behind those windows? Pharmalot reports that, after a recent visit, FDA2012/1/11
-
Novartis pulls OTC meds made at troubled plantOn the heels of a temporary plant shutdown last month, Novartis ($NVS) has recalled four over-the-counter drugs made there. It's a precautionary recall, the company's consumer health division report2012/1/11
-
European Pharma Industry Seen ‘Rising From the Ashes’ in Mid-2012By Sten Stovall Investment prospects for Europe’s big drug makers look set to improve dramatically from mid-2012, despite the gloomy backdrop facing the sector as the year begins. In 2012, th2012/1/10
-
Pfizer’s Lipitor Market Share to Fall More, Watson CEO SaysPfizer Inc. (PFE)’s market share for the cholesterol pill Lipitor (PHAM1150), now at 41 percent after losing patent protection last year, will decline further in the next five months, according to gen2012/1/10
-
Americans cutting costs by skipping prescription drugsBy Dr Ananya Mandal, MD A Consumer Reports survey revealed that more Americans are ignoring their doctor’s advice and skipping prescription drugs or medical procedures to save money in 2011 than a2012/1/9
-
Challenges in new product planning and development process for pharmaceutical industryThe new product planning and development process is fraught with challenges, from regulatory requirements and safety concerns to cost constraints and competitive pressures. New product planning lead2012/1/9
-
SFDA issues Measures for Food and Drug Complaint Report (interim)In order to standardize the management of food and drug complaint report, firmly crackdown on illegal activities, and ensure food and drug safety for the public, the State Food and Drug Administ2012/1/9
-
Scientists identify how dihydromyricetin counteracts acute alcohol intoxicationUCLA researchers have identified how a component of an ancient Chinese herbal anti-hangover medicine called dihydromyricetin, isolated from the plant Hovenia, counteracts acute alcohol intoxication2012/1/6
-
Sanofi granted preliminary injunction to prevent launch of Seikagaku's Synvisc-OneSanofi US today announced that the U. S. District Court in Massachusetts granted the company a preliminary injunction against a Synvisc-One® (hylan G-F 20) competitor product developed by Seikagak2012/1/6
-
Cost paid for statins 400% higher in the U.S. than U.K.In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance is approximately 400 percent higher than comparable costs paid b2012/1/6